Navigation Links
Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
Date:8/15/2013

BLUE BELL, Pa., Aug. 15, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its SynCon® DNA vaccine containing multiple malaria antigens delivered via its CELLECTRA® electroporation device demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates. With these strong preclinical results, Inovio plans to initiate a phase I/IIa clinical trial next year.

These results appear in the American Society for Microbiology's peer-reviewed journal, Infection & Immunity, in a paper entitled: "Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using pDNA," authored by Inovio researchers and collaborators.

The World Health Organization estimated that in 2010 there were more than 200 million cases of malaria and almost 700,000 deaths due to malaria infection, the majority affecting young children in Africa. To date, the most advanced malaria vaccine candidate RTS,S, an adjuvanted recombinant protein vaccine, has not shown substantial protection in the key trial age group of infants. Scientists believe that a more effective malaria vaccine should generate both strong antibody and potent T-cell immune responses.

In this study, Inovio researchers and collaborators designed a highly optimized DNA vaccine composed of four sporozoite and liver-stage malaria antigens using Inovio's SynCon technology. These antigens were chosen because of their important role in the control or elimination of malaria infection. Delivered using Inovio's CELLECTRA delivery system, this malaria vaccine generated robust and long-lasting T-cell responses in both mice and non-human primates. Moreover, these vaccine-produced T-cells exhibited the functional ability to kill and eliminate malaria-infected cells. Researchers also found vaccine-induced CD8+, or "kille
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results
2. Inovio Pharmaceuticals Responds to Market Activity
3. Inovio Pharmaceuticals Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence
4. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
5. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
6. Inovio Pharmaceuticals to Present at OneMedForumNY 2013 Investor Conference
7. Inovios Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
8. Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
9. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
10. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
11. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... According to a new market ... Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air ... & Forecast to 2019", published by MarketsandMarkets, the global ... 2014 and is estimated to grow to $1,425.7 Million ... 2014 to 2019. Browse 41 market ...
(Date:7/30/2015)... DIEGO , July 30, 2015 /PRNewswire/ ... it has signed a definitive agreement to ... of non-invasive ventilation and sleep-disordered breathing medical ... clinical, innovation and market reputation in China, combined with ResMed,s global leadership in ... people in China ...
(Date:7/30/2015)...  EP Global Communications, Inc. (Public OTC: EPGL) announced today ... Company about discussing EPGL,s electronic contact lens technologies.  ... 3, 2015.  Novartis CEO Joe Jimenez ... electronic contact lens market could be worth tens ... years.  Novartis partnered with Google in 2014 to ...
Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... Medical Technologies announced today the release of its ... view used to navigate multiple planes simultaneously. This ... pulmonology, enabling physicians to view the location of ... view without any radiation being delivered to the ...
... BOCA RATON, Fla. and FARGO, N.D., Dec. 16, 2011  Crystal3 ... in Boca Raton, FL, announced today that it has ... of Fargo, ND. Financial terms of the transaction were ... change to Global Pharma Analytics. Founded in ...
Cached Medicine Technology:Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View 2Crystal3 Labs Acquired by Individual Investor, Vithalbhai Dhaduk, M.D. 2
(Date:8/1/2015)... , ... August 01, 2015 , ... The condition where ... both men and women often causing pain and discomfort. Those who spend a lot ... problem, and Northeast Houston Vein Center is doing what it can to create awareness ...
(Date:8/1/2015)... ... August 01, 2015 , ... Professional ... portfolio company has acquired Premier Physical Therapy & Wellness (“Premier”) — with 13 ... state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy & Wellness solidifies Professional ...
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on ... and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the ... allows users to clarify, edit and delete any message including ones already sent. , ...
(Date:7/31/2015)... ... 31, 2015 , ... When the weather turned hot and warm-season turfgrasses, such ... sod called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) for short. Incidentally, both ... this new type of sod, Super-Sod is giving away red Adirondack chairs with the ...
(Date:7/31/2015)... ... ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and black diamond ... non-surgical fat reduction in New York. Due to its unparalleled level of experience ... Many patients travel to New York to get their non-surgical skin tightening and body ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
... to Go Pink in October, HARRISBURG, Pa., Sept. ... pink as the Pennsylvania,Commission for Women kicks-off Breast Cancer ... have so valiantly fought the disease., The commission ... as,a tool to educate the public on the disease., ...
... Inc., a,global supplier of private-label infant formulas, announced ... more retailers are looking to offer,formulas manufactured in ... of mothers and fathers in Canada understand that ... there is a savings,up to 50 percent, PBM ...
... interventional techniques and devices will be released at ... global annual scientific symposium of the Cardiovascular Research ... data that promises to advance the field of ... safety and efficacy of new devices, including drug-eluting ...
... Offset by Charge for Goodwill Impairment, SALT LAKE ... today announced results for its fourth quarter,and fiscal 2008 ... acquisitions concluded in the fourth,quarter of fiscal year 2007 ... recorded significant revenue increases for the fourth quarter and,full ...
... SAN FRANCISCO, Sept. 29 Since the death of ... Hospital in Bangkok, Thailand,James Goldberg has attempted to see ... the story to its roots, I was astounded to ... of the American public,due in part to rubber stamp ...
... up 12.2 ... costs, CHICAGO, Sept. 29 Hospital-acquired,infections, hospital-acquired ... for one out of every six claims, according ... Benchmark,Analysis, released today by leading risk management services ...
Cached Medicine News:Health News:PA Commission for Women Kicks Off Breast Cancer Awareness Month With Pink Fountain Tour 2Health News:Canadian Brand-Name Infant Formulas No Better than Private-Label Formulas 2Health News:TCT update: press conference schedule announced for TCT 2Health News:TCT update: press conference schedule announced for TCT 3Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 2Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 3Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 4Health News:Dynatronics Announces Fiscal Year 2008 Operating Results 5Health News:New Trend of Healthcare Companies Sending Patients Abroad for Surgery is Dangerous Says James Goldberg Whose Son Died Following Surgery in Thailand 2Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 2Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 3Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 4Health News:'Never Events' Responsible for One Out of Six Med Mal Liability Claims, Says Aon 5